健康社会决定因素对脂肪性肝病患者死亡率、新发肝脏相关事件及心血管疾病的影响
该回顾性队列研究纳入密歇根医学院15,904例代谢功能障碍相关脂肪性肝病(MASLD)患者,中位随访63个月,评估邻里层面SDOH(劣势与富裕)对死亡率、新发肝脏相关事件(LREs)和新发心血管疾病(CVD)的影响。结果显示高富裕与较低死亡、LREs和CVD风险相关,高劣势与较高死亡和CVD风险相关,且敏感性分析结果稳健。
要点
- 高富裕与较低全因死亡风险相关(HR 0.49)。
- 高劣势与较高全因死亡风险相关(HR 2.08)。
- 邻里层面SDOH与MASLD患者死亡、LREs和CVD相关。
核心结论
- 邻里层面健康社会决定因素与脂肪性肝病患者的死亡率、肝脏相关事件发生率及心血管疾病发生率相关。
- 针对劣势社区的干预可能改善临床结局。
研究设计与样本
- 回顾性队列研究,纳入密歇根医学院就诊的MASLD患者15,904例,中位随访63个月。
- 主要预测因素为邻里层面SDOH的两个维度:劣势和富裕。
- 主要结局为死亡率、新发肝脏相关事件(LREs)和新发心血管疾病(CVD),采用Kaplan-Meier统计和竞争风险分析,并使用1年地标法。
主要发现
- 高富裕(最高四分位 vs 最低四分位)与较低全因死亡风险相关(HR 0.49 [0.37-0.66],p < 0.0001)。
- 高富裕与较低LREs风险相关(亚分布风险比 0.60 [0.39-0.91],p = 0.02)。
- 高富裕与较低CVD风险相关(亚分布风险比 0.71 [0.57-0.88],p = 0.0018)。
- 高劣势(最高四分位 vs 最低四分位)与较高全因死亡风险相关(HR 2.08 [95%CI 1.54-2.81],p < 0.0001)。
- 高劣势与较高新发CVD风险相关(亚分布风险比 1.36 [95%CI 1.10-1.68],p < 0.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Social determinants of health (SDOH) are becoming increasingly recognised as mediators of human health. In the setting of metabolic dysfunction-associated steatotic liver disease (MASLD), most of the literature on SDOH relates to individual-level risk factors. However, there are very limited data on neighbourhood-level SDOH in MASLD. AIM: To assess whether SDOH impact fibrosis progression in patients who already have MASLD. METHODS: This was a retrospective cohort study of patients with MASLD seen at Michigan Medicine. The primary predictors were two neighbourhood-level SDOH, 'disadvantage' and 'affluence'. The primary outcomes were mortality, incident liver-related events (LREs) and incident cardiovascular disease (CVD). We modelled these outcomes using Kaplan-Meier statistics for mortality and competing risk analyses for LREs and CVD, using a 1-year landmark. RESULTS: We included 15,904 patients with MASLD with median follow-up of 63 months. Higher affluence was associated with lower risk of overall mortality (hazard ratio 0.49 [0.37-0.66], p < 0.0001 for higher vs. lower quartile), LREs (subhazard ratio 0.60 [0.39-0.91], p = 0.02) and CVD (subhazard ratio 0.71 [0.57-0.88], p = 0.0018). Disadvantage was associated with higher mortality (hazard ratio 2.08 [95% confidence interval 1.54-2.81], p < 0.0001 for the highest vs. lowest quartile) and incident CVD (subhazard ratio 1.36 [95% confidence interval 1.10-1.68], p < 0.0001). These findings were robust across several sensitivity analyses. DISCUSSION: Neighbourhood-level SDOH are associated with mortality, incidence of LREs and incident CVD in patients with steatotic liver disease. Interventions aimed at disadvantaged neighbourhoods may improve clinical outcomes.
引用
- Chen VL, Song MW, Suresh D, et al. Effects of social determinants of health on mortality and incident liver-related events and cardiovascular disease in steatotic liver disease. Aliment Pharmacol Ther. 2023. PMID: 37394976. doi:10.1111/apt.17631
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。